326 related articles for article (PubMed ID: 11698284)
1. Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART.
Kulkosky J; Culnan DM; Roman J; Dornadula G; Schnell M; Boyd MR; Pomerantz RJ
Blood; 2001 Nov; 98(10):3006-15. PubMed ID: 11698284
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of HIV receptor and co-receptor down-regulation by prostratin: role of conventional and novel PKC isoforms.
Hezareh M; Moukil MA; Szanto I; Pondarzewski M; Mouche S; Cherix N; Brown SJ; Carpentier JL; Foti M
Antivir Chem Chemother; 2004 Jul; 15(4):207-22. PubMed ID: 15457682
[TBL] [Abstract][Full Text] [Related]
3. 4-Deoxyphorbol inhibits HIV-1 infection in synergism with antiretroviral drugs and reactivates viral reservoirs through PKC/MEK activation synergizing with vorinostat.
De la Torre-Tarazona HE; Jiménez R; Bueno P; Camarero S; Román L; Fernández-García JL; Beltrán M; Nothias LF; Cachet X; Paolini J; Litaudon M; Alcami J; Bedoya LM
Biochem Pharmacol; 2020 Jul; 177():113937. PubMed ID: 32224142
[TBL] [Abstract][Full Text] [Related]
4. Prostratin as a new therapeutic agent targeting HIV viral reservoirs.
Hezareh M
Drug News Perspect; 2005 Oct; 18(8):496-500. PubMed ID: 16391719
[TBL] [Abstract][Full Text] [Related]
5. Dual role of prostratin in inhibition of infection and reactivation of human immunodeficiency virus from latency in primary blood lymphocytes and lymphoid tissue.
Biancotto A; Grivel JC; Gondois-Rey F; Bettendroffer L; Vigne R; Brown S; Margolis LB; Hirsch I
J Virol; 2004 Oct; 78(19):10507-15. PubMed ID: 15367617
[TBL] [Abstract][Full Text] [Related]
6. HIV type 1 inhibition by protein kinase C modulatory compounds.
Warrilow D; Gardner J; Darnell GA; Suhrbier A; Harrich D
AIDS Res Hum Retroviruses; 2006 Sep; 22(9):854-64. PubMed ID: 16989610
[TBL] [Abstract][Full Text] [Related]
7. Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection.
Reuse S; Calao M; Kabeya K; Guiguen A; Gatot JS; Quivy V; Vanhulle C; Lamine A; Vaira D; Demonte D; Martinelli V; Veithen E; Cherrier T; Avettand V; Poutrel S; Piette J; de Launoit Y; Moutschen M; Burny A; Rouzioux C; De Wit S; Herbein G; Rohr O; Collette Y; Lambotte O; Clumeck N; Van Lint C
PLoS One; 2009 Jun; 4(6):e6093. PubMed ID: 19564922
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of phorbol-13-monoesters on human immunodeficiency virus reactivation.
Márquez N; Calzado MA; Sánchez-Duffhues G; Pérez M; Minassi A; Pagani A; Appendino G; Diaz L; Muñoz-Fernández MA; Muñoz E
Biochem Pharmacol; 2008 Mar; 75(6):1370-80. PubMed ID: 18241838
[TBL] [Abstract][Full Text] [Related]
9. Highly potent, synthetically accessible prostratin analogs induce latent HIV expression in vitro and ex vivo.
Beans EJ; Fournogerakis D; Gauntlett C; Heumann LV; Kramer R; Marsden MD; Murray D; Chun TW; Zack JA; Wender PA
Proc Natl Acad Sci U S A; 2013 Jul; 110(29):11698-703. PubMed ID: 23812750
[TBL] [Abstract][Full Text] [Related]
10. Effects of prostratin on T-cell activation and human immunodeficiency virus latency.
Korin YD; Brooks DG; Brown S; Korotzer A; Zack JA
J Virol; 2002 Aug; 76(16):8118-23. PubMed ID: 12134017
[TBL] [Abstract][Full Text] [Related]
11. Promising Role of Toll-Like Receptor 8 Agonist in Concert with Prostratin for Activation of Silent HIV.
Rochat MA; Schlaepfer E; Speck RF
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928016
[TBL] [Abstract][Full Text] [Related]
12. Prostratin induces HIV activation and downregulates HIV receptors in peripheral blood lymphocytes.
Rullas J; Bermejo M; García-Pérez J; Beltán M; González N; Hezareh M; Brown SJ; Alcamí J
Antivir Ther; 2004 Aug; 9(4):545-54. PubMed ID: 15456086
[TBL] [Abstract][Full Text] [Related]
13. Effects of prostratin on Cyclin T1/P-TEFb function and the gene expression profile in primary resting CD4+ T cells.
Sung TL; Rice AP
Retrovirology; 2006 Oct; 3():66. PubMed ID: 17014716
[TBL] [Abstract][Full Text] [Related]
14. Activation of latent HIV-1 expression by the potent anti-tumor promoter 12-deoxyphorbol 13-phenylacetate.
Bocklandt S; Blumberg PM; Hamer DH
Antiviral Res; 2003 Jul; 59(2):89-98. PubMed ID: 12895692
[TBL] [Abstract][Full Text] [Related]
15. IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART.
Wang FX; Xu Y; Sullivan J; Souder E; Argyris EG; Acheampong EA; Fisher J; Sierra M; Thomson MM; Najera R; Frank I; Kulkosky J; Pomerantz RJ; Nunnari G
J Clin Invest; 2005 Jan; 115(1):128-37. PubMed ID: 15630452
[TBL] [Abstract][Full Text] [Related]
16. Prostratin antagonizes HIV latency by activating NF-kappaB.
Williams SA; Chen LF; Kwon H; Fenard D; Bisgrove D; Verdin E; Greene WC
J Biol Chem; 2004 Oct; 279(40):42008-17. PubMed ID: 15284245
[TBL] [Abstract][Full Text] [Related]
17. BI-2536 and BI-6727, dual Polo-like kinase/bromodomain inhibitors, effectively reactivate latent HIV-1.
Gohda J; Suzuki K; Liu K; Xie X; Takeuchi H; Inoue JI; Kawaguchi Y; Ishida T
Sci Rep; 2018 Feb; 8(1):3521. PubMed ID: 29476067
[TBL] [Abstract][Full Text] [Related]
18. Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains.
Huang L; Bosch I; Hofmann W; Sodroski J; Pardee AB
J Virol; 1998 Nov; 72(11):8952-60. PubMed ID: 9765440
[TBL] [Abstract][Full Text] [Related]
19. Expression of latent HAART-persistent HIV type 1 induced by novel cellular activating agents.
Kulkosky J; Sullivan J; Xu Y; Souder E; Hamer DH; Pomerantz RJ
AIDS Res Hum Retroviruses; 2004 May; 20(5):497-505. PubMed ID: 15186524
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of HIV coreceptors CXCR4 and CCR5 on CD4(+) T cells during human endotoxemia and after stimulation with (myco)bacterial antigens: the role of cytokines.
Juffermans NP; Paxton WA; Dekkers PE; Verbon A; de Jonge E; Speelman P; van Deventer SJ; van der Poll T
Blood; 2000 Oct; 96(8):2649-54. PubMed ID: 11023494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
